200 related articles for article (PubMed ID: 9724291)
1. ET-receptor antagonism, myocardial gene expression, and ventricular remodeling during CHF in rats.
Oie E; Bjønerheim R; Grogaard HK; Kongshaug H; Smiseth OA; Attramadal H
Am J Physiol; 1998 Sep; 275(3):H868-77. PubMed ID: 9724291
[TBL] [Abstract][Full Text] [Related]
2. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling.
Mulder P; Richard V; Derumeaux G; Hogie M; Henry JP; Lallemand F; Compagnon P; Macé B; Comoy E; Letac B; Thuillez C
Circulation; 1997 Sep; 96(6):1976-82. PubMed ID: 9323089
[TBL] [Abstract][Full Text] [Related]
3. Early intervention with a potent endothelin-A/endothelin-B receptor antagonist aggravates left ventricular remodeling after myocardial infarction in rats.
Oie E; Yndestad A; Robins SP; Børnerheim R; Asberg A; Attramadal H
Basic Res Cardiol; 2002 May; 97(3):239-47. PubMed ID: 12061394
[TBL] [Abstract][Full Text] [Related]
4. Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: possible involvement of myocardial endothelin system in ventricular remodeling.
Fraccarollo D; Hu K; Galuppo P; Gaudron P; Ertl G
Circulation; 1997 Dec; 96(11):3963-73. PubMed ID: 9403621
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of angiotensin II versus endothelin-1 inhibitions in hypertrophic left ventricular myocardium during transition to heart failure.
Iwanaga Y; Kihara Y; Inagaki K; Onozawa Y; Yoneda T; Kataoka K; Sasayama S
Circulation; 2001 Jul; 104(5):606-12. PubMed ID: 11479261
[TBL] [Abstract][Full Text] [Related]
6. Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats.
Iwanaga Y; Kihara Y; Hasegawa K; Inagaki K; Yoneda T; Kaburagi S; Araki M; Sasayama S
Circulation; 1998 Nov; 98(19):2065-73. PubMed ID: 9808606
[TBL] [Abstract][Full Text] [Related]
7. Selective ETA receptor blockade prevents left ventricular remodeling and deterioration of cardiac function in experimental heart failure.
Mulder P; Richard V; Bouchart F; Derumeaux G; Münter K; Thuillez C
Cardiovasc Res; 1998 Sep; 39(3):600-8. PubMed ID: 9861302
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival and hemodynamics after endothelin-a receptor antagonism and angiotensin-converting enzyme inhibition in rats with chronic heart failure: monotherapy versus combination therapy.
Mulder P; Boujedaini H; Richard V; Henry JP; Renet S; Münter K; Thuillez C
Circulation; 2002 Aug; 106(9):1159-64. PubMed ID: 12196345
[TBL] [Abstract][Full Text] [Related]
9. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan).
Teerlink JR; Löffler BM; Hess P; Maire JP; Clozel M; Clozel JP
Circulation; 1994 Nov; 90(5):2510-8. PubMed ID: 7955209
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin A inhibits cardiac hypertrophy and enhances cardiac dysfunction during postinfarction failure in rats.
Oie E; Bjørnerheim R; Clausen OP; Attramadal H
Am J Physiol Heart Circ Physiol; 2000 Jun; 278(6):H2115-23. PubMed ID: 10843911
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist.
Kaddoura S; Firth JD; Boheler KR; Sugden PH; Poole-Wilson PA
Circulation; 1996 Jun; 93(11):2068-79. PubMed ID: 8640984
[TBL] [Abstract][Full Text] [Related]
12. Effects of nonselective endothelin-1 receptor antagonism on cardiac mast cell-mediated ventricular remodeling in rats.
Murray DB; Gardner JD; Brower GL; Janicki JS
Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1251-7. PubMed ID: 18178727
[TBL] [Abstract][Full Text] [Related]
13. Endothelin receptor antagonism attenuates cardiomyocyte apoptosis after induction of ischemia in rats.
Oie E; Clausen OP; Yndestad A; Grøgaard HK; Attramadal H
Scand Cardiovasc J; 2002 Mar; 36(2):108-16. PubMed ID: 12028875
[TBL] [Abstract][Full Text] [Related]
14. Chronic administration of an endothelin-A receptor antagonist improves exercise capacity in rats with myocardial infarction-induced congestive heart failure.
Miyauchi T; Fujimori A; Maeda S; Iemitsu M; Sakai S; Shikama H; Tanabe T; Matsuda M; Goto K; Yamaguchi I
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S64-7. PubMed ID: 15838361
[TBL] [Abstract][Full Text] [Related]
15. YM598, an orally active ET(A) receptor antagonist, ameliorates the progression of cardiopulmonary changes and both-side heart failure in rats with cor pulmonale and myocardial infarction.
Fujimori A; Miyauchi T; Sakai S; Yuyama H; Iemitsu M; Sanagi M; Sudoh K; Goto K; Shikama H; Yamaguchi I
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S354-7. PubMed ID: 15838319
[TBL] [Abstract][Full Text] [Related]
16. Selective endothelin-A versus combined endothelin-A/endothelin-B receptor blockade in rat chronic heart failure.
Mulder P; Boujedaini H; Richard V; Derumeaux G; Henry JP; Renet S; Wessale J; Opgenorth T; Thuillez C
Circulation; 2000 Aug; 102(5):491-3. PubMed ID: 10920058
[TBL] [Abstract][Full Text] [Related]
17. Role of endothelin in deterioration of heart failure due to cardiomyopathy in hamsters: increase in endothelin-1 production in the heart and beneficial effect of endothelin-A receptor antagonist on survival and cardiac function.
Yamauchi-Kohno R; Miyauchi T; Hoshino T; Kobayashi T; Aihara H; Sakai S; Yabana H; Goto K; Sugishita Y; Murata S
Circulation; 1999 Apr; 99(16):2171-6. PubMed ID: 10217659
[TBL] [Abstract][Full Text] [Related]
18. Chronic endothelin receptor blockade prevents renal vasoconstriction and sodium retention in rats with chronic heart failure.
Ding SS; Qiu C; Hess P; Xi JF; Clozel JP; Clozel M
Cardiovasc Res; 2002 Mar; 53(4):963-70. PubMed ID: 11922906
[TBL] [Abstract][Full Text] [Related]
19. Urotensin-II blockade with SB-611812 attenuates cardiac dysfunction in a rat model of coronary artery ligation.
Bousette N; Hu F; Ohlstein EH; Dhanak D; Douglas SA; Giaid A
J Mol Cell Cardiol; 2006 Aug; 41(2):285-95. PubMed ID: 16797584
[TBL] [Abstract][Full Text] [Related]
20. Effect of endothelin receptor antagonists on ventricular susceptibility in postinfarcted rats.
Lee TM; Chen CC; Lin MS; Chang NC
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1871-9. PubMed ID: 18281380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]